Stroke prevention in atrial fibrillation.

@article{Mohammed2012StrokePI,
  title={Stroke prevention in atrial fibrillation.},
  author={Ilyas Mohammed and Adam Mohmand-Borkowski and James F. Burke and Peter Russell Kowey},
  journal={Journal of cardiovascular medicine},
  year={2012},
  volume={13 2},
  pages={73-85}
}
Atrial fibrillation (AF) is a common arrhythmia associated with substantial morbidity and mortality, particularly due to thromboembolic strokes, the prevalence of which is expected to rise over the next few decades. This article reviews the complex mechanisms behind thromboembolism, compares the newer risk stratification models for identifying those at risk for stroke or bleeding, and highlights the potential advantages and disadvantages of available therapies. Newer oral anticoagulants like… CONTINUE READING

Connections & Topics

Mentioned Connections BETA
This article is intended to help clinicians gain a better understanding of available risk stratification tools and therapies available for prevention of stroke in patients with atrial fibrillation .
Atrial fibrillation ( AF ) is a common arrhythmia associated with substantial morbidity and mortality , particularly due to thromboembolic strokes , the prevalence of which is expected to rise over the next few decades .
Stroke prevention in atrial fibrillation .
Atrial fibrillation ( AF ) is a common arrhythmia associated with substantial morbidity and mortality , particularly due to thromboembolic strokes , the prevalence of which is expected to rise over the next few decades .
Stroke prevention in atrial fibrillation .
This article is intended to help clinicians gain a better understanding of available risk stratification tools and therapies available for prevention of stroke in patients with atrial fibrillation .
This article reviews the complex mechanisms behind thromboembolism , compares the newer risk stratification models for identifying those at risk for stroke or bleeding , and highlights the potential advantages and disadvantages of available therapies .
This article reviews the complex mechanisms behind thromboembolism , compares the newer risk stratification models for identifying those at risk for stroke or bleeding , and highlights the potential advantages and disadvantages of available therapies .
This article reviews the complex mechanisms behind thromboembolism , compares the newer risk stratification models for identifying those at risk for stroke or bleeding , and highlights the potential advantages and disadvantages of available therapies .
This article reviews the complex mechanisms behind thromboembolism , compares the newer risk stratification models for identifying those at risk for stroke or bleeding , and highlights the potential advantages and disadvantages of available therapies .
There is also discussion on non pharmacological therapies such as left atrial appendage ligation and occlusion devices .
Newer oral anticoagulants like Dabigatran , Rivoroxaban , and Apixiban are discussed .
Newer oral anticoagulants like Dabigatran , Rivoroxaban , and Apixiban are discussed .
All Topics